Active, Not Recruiting
Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
NCT05000710
- Conditions
- Metastatic or Locally Advanced NSCLC, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Sheba Medical Centre Ramat Gan, Israel